-
Alteration of skeletal muscle energy metabolism assessed by 31P MRS in clinical routine, part 1: Advanced Quality Control pipeline
Authors:
Antoine Naëgel,
Hélène Ratiney,
Jabrane Karkouri,
Djahid Kennouche,
Nicolas Royer,
Jill M Slade,
Jérôme Morel,
Pierre Croisille,
Magalie Viallon
Abstract:
Background: Implementing a standardized 31P-MRS dynamic acquisition protocol to evaluate skeletal muscle energy metabolism and monitor muscle fatigability1,2, while being compatible with various longitudinal clinical studies on diversified patient cohorts, requires a high level of technicality and expertise. Furthermore, processing data to obtain reliable results also demands a great degree of exp…
▽ More
Background: Implementing a standardized 31P-MRS dynamic acquisition protocol to evaluate skeletal muscle energy metabolism and monitor muscle fatigability1,2, while being compatible with various longitudinal clinical studies on diversified patient cohorts, requires a high level of technicality and expertise. Furthermore, processing data to obtain reliable results also demands a great degree of expertise from the operator. In this two-part article, we present an advanced quality control approach for data acquired using a dynamic 31P-MRS protocol. The aim is to provide decision support to the operator in order to assist in data processing and obtain reliable results based on objective criteria. We present first in part one, an advanced data quality control (QC) approach of a dynamic 31P-MRS protocol. Part two is an impact study demonstrating the added value of the QC approach to explore clinical results derived from two patient populations with significant fatigue: COVID19 and multiple sclerosis (MS). Experimental: 31P-MRS was performed on a 3T clinical MRI in 175 subjects from clinical and healthy control populations conducted in a University Hospital. An advanced data QC Score (QCS) was developed using multiple objective criteria. The criteria were based on current recommendations from the literature enriched by new proposals based on clinical experience. The QCS was designed to indicate valid and corrupt data and guide necessary objective data editing to extract as much valid physiological data as possible. Dynamic acquisitions using an MR-compatible ergometer ran over a rest(40s), exercise(2min), and a recovery phase(6min). Results: Using QCS enabled rapid identification of subjects with data anomalies allowing the user to correct the data series or reject them partially or entirely as well as identify fully valid datasets. Overall, the use of the QCS resulted in the automatic classification of 45% of the subjects including 58 participants that had data with no criterion violation and 21 participants with violations that resulted in the rejection of all dynamic data. The remaining datasets were inspected manually with guidance allowing acceptance of full datasets from an additional 80 participants and recovery phase data from an additional 16 subjects. Overall, more anomalies occurred with patient data (35% of datasets) compared to healthy controls (15% of datasets). Conclusion: This paper describes typical difficulties encountered during the dynamic acquisition of 31P-MRS. Based on these observations, a standardized data quality control pipeline was created and implemented in both healthy and patient populations. The QC scoring ensures a standardized data rejection procedure and rigorous objective analysis of dynamic 31P-MRS data obtained from patients. The contribution of this methodology contributes to efforts made to standardize the practices of the 31P-MRS that has been underway for a decade, with the ultimate goal of making it an empowered tool for clinical research.
△ Less
Submitted 22 September, 2023;
originally announced September 2023.
-
Alteration of skeletal muscle energy metabolism assessed by 31P MRS in clinical routine, part 2: Clinical application
Authors:
Antoine Naëgel,
Hélène Ratiney,
Jabrane Karkouri,
Djahid Kennouche,
Nicolas Royer,
Jill M Slade,
Jérôme Morel,
Pierre Croisille,
Magalie Viallon
Abstract:
Background: In this second part of a two-part paper, we intend to demonstrate the impact of the previously proposed advanced quality control pipeline. To understand its benefit and challenge the proposed methodology in a real scenario, we chose to compare the outcome when applying it to the analysis of two patient populations with a significant but highly different types of fatigue: COVID19 and mu…
▽ More
Background: In this second part of a two-part paper, we intend to demonstrate the impact of the previously proposed advanced quality control pipeline. To understand its benefit and challenge the proposed methodology in a real scenario, we chose to compare the outcome when applying it to the analysis of two patient populations with a significant but highly different types of fatigue: COVID19 and multiple sclerosis (MS). Experimental: 31P-MRS was performed on a 3T clinical MRI, in 19 COVID19 patients, 38 MS patients, and 40 matched healthy controls. Dynamic acquisitions using an MR-compatible ergometer ran over a rest(40s), exercise(2min), and a recovery phase(6min). Long and short TR acquisitions were also made at rest for T1 correction. The advanced data quality control pipeline presented in part 1 is applied to the selected patient cohorts to investigate its impact on clinical outcomes. We first used power and sample size analysis to estimate objectively the impact of adding QCS. Then, comparisons between patients and healthy control groups using validated QCS were performed using unpaired T-tests or Mann-Whitney tests (p<0.05).Results: The application of the QCS resulted in increased statistical power, changed the values of several outcome measures, and reduced variability (SD). A significant difference was found between the T1PCr and T1Pi of MS patients and healthy controls. Furthermore, the use of a fixed correction factor led to systematically higher estimated concentrations of PCr and Pi than when using individually corrected factors. We observed significant differences between the two patient populations and healthy controls for resting [PCr] -- MS only, [Pi], [ADP], [H2PO4-] and pH -- COVID19 only, and post-exercise [PCr],[Pi] and [H2PO4-] - MS only. The dynamic indicators $τ$PCr, $τ$Pi, ViPCr and Vmax were reduced for COVID19 and MS patients compared to controls. Conclusion: Our results show that QCS in dynamic 31P-MRS studies results in smaller data variability and therefore impacts study sample size and power. Although QCS resulted in discarded data and therefore reduced the acceptable data and subject numbers, this rigorous and unbiased approach allowed for proper assessment of muscle metabolites and metabolism in patient populations. The outcomes include an increased metabolite T1, which directly affect the T1 correction factor applied to the amplitudes of the metabolite, and a prolonged $τ$PCr indicating reduced muscle oxidative capacity for patients with MS and COVID19.
△ Less
Submitted 21 September, 2023;
originally announced September 2023.
-
Validation of apparent intra-and extra-myocellular lipid content indicator using spiral spectroscopic imaging at 3T
Authors:
Antoine Naëgel,
Magalie Viallon,
Jabrane Karkouri,
Thomas Troalen,
Pierre Croisille,
Hélène Ratiney
Abstract:
This work presents a fast and simple method based on spiral MRSI for map** the IMCL and EMCL apparent content, which is a challenging task and it compares this indicator to classical quantification results in muscles of interest.
This work presents a fast and simple method based on spiral MRSI for map** the IMCL and EMCL apparent content, which is a challenging task and it compares this indicator to classical quantification results in muscles of interest.
△ Less
Submitted 22 August, 2023;
originally announced August 2023.
-
Towards Super-Resolution CEST MRI for Visualization of Small Structures
Authors:
Lukas Folle,
Katharian Tkotz,
Fasil Gadjimuradov,
Lorenz Kapsner,
Moritz Fabian,
Sebastian Bickelhaupt,
David Simon,
Arnd Kleyer,
Gerhard Krönke,
Moritz Zaiß,
Armin Nagel,
Andreas Maier
Abstract:
The onset of rheumatic diseases such as rheumatoid arthritis is typically subclinical, which results in challenging early detection of the disease. However, characteristic changes in the anatomy can be detected using imaging techniques such as MRI or CT. Modern imaging techniques such as chemical exchange saturation transfer (CEST) MRI drive the hope to improve early detection even further through…
▽ More
The onset of rheumatic diseases such as rheumatoid arthritis is typically subclinical, which results in challenging early detection of the disease. However, characteristic changes in the anatomy can be detected using imaging techniques such as MRI or CT. Modern imaging techniques such as chemical exchange saturation transfer (CEST) MRI drive the hope to improve early detection even further through the imaging of metabolites in the body. To image small structures in the joints of patients, typically one of the first regions where changes due to the disease occur, a high resolution for the CEST MR imaging is necessary. Currently, however, CEST MR suffers from an inherently low resolution due to the underlying physical constraints of the acquisition. In this work we compared established up-sampling techniques to neural network-based super-resolution approaches. We could show, that neural networks are able to learn the map** from low-resolution to high-resolution unsaturated CEST images considerably better than present methods. On the test set a PSNR of 32.29dB (+10%), a NRMSE of 0.14 (+28%), and a SSIM of 0.85 (+15%) could be achieved using a ResNet neural network, improving the baseline considerably. This work paves the way for the prospective investigation of neural networks for super-resolution CEST MRI and, followingly, might lead to a earlier detection of the onset of rheumatic diseases.
△ Less
Submitted 3 December, 2021;
originally announced December 2021.
